Publications

Nonverbal connection is an important aspect of everyday communication. For romantic partners, nonverbal connection is essential for establishing and maintaining feelings of closeness. EEG hyperscanning offers a unique opportunity to examine the link between nonverbal connection and neural synchrony among romantic partners. This current study used an EEG hyperscanning paradigm to collect frontal alpha asymmetry (FAA) signatures from 30 participants (15 romantic dyads) engaged in five different types of nonverbal connection that varied based on physical touch and visual contact. The results suggest that there was a lack of FAA while romantic partners were embracing and positive FAA (i.e., indicating approach) while they were holding hands, looking at each other, or doing both. Additionally, partners' FAA synchrony was greatest at a four second lag while they were holding hands and looking at each other. Finally, there was a significant association between partners' weekly negative feelings and FAA such that as they felt more negative their FAA became more positive. Taken together, this study further supports the idea that fleeting moments of interpersonal touch and gaze are important for the biological mechanisms that may underlie affiliative pair bonding in romantic relationships.

Patients with neurocognitive disorders often battle sleep disturbances. Kynurenic acid is a tryptophan metabolite of the kynurenine pathway implicated in the pathology of these illnesses. Modest increases in kynurenic acid, an antagonist at glutamatergic and cholinergic receptors, result in cognitive impairments and sleep dysfunction. We explored the hypothesis that inhibition of the kynurenic acid synthesising enzyme, kynurenine aminotransferase II, may alleviate sleep disturbances. At the start of the light phase, adult male and female Wistar rats received systemic injections of either: (i) vehicle; (ii) kynurenine (100 mg kg-1; i.p.); (iii) the kynurenine aminotransferase II inhibitor, PF-04859989 (30 mg kg-1; s.c.); or (iv) PF-04859989 and kynurenine in combination. Kynurenine and kynurenic acid levels were evaluated in the plasma and brain. Separate animals were implanted with electroencephalogram and electromyogram telemetry devices to record polysomnography, and evaluate the vigilance states wake, rapid eye movement sleep and non-rapid eye movement sleep following each treatment. Kynurenine challenge increased brain kynurenic acid and resulted in reduced rapid eye movement sleep duration, non-rapid eye movement sleep delta power and sleep spindles. PF-04859989 reduced brain kynurenic acid formation when given prior to kynurenine, prevented disturbances in rapid eye movement sleep and sleep spindles, and enhanced non-rapid eye movement sleep. Our findings suggest that reducing kynurenic acid in conditions where the kynurenine pathway is activated may serve as a potential strategy for improving sleep dynamics.